** charts before earnings **
- 3 days before
** charts after earnings **
- Reports Q3 (Sep) adj. loss of $0.08 per share, $0.04 better than the S&P Capital IQ Consensus of ($0.12); revenues rose 85.2% year/year to $10 mln vs the $10.25 mln S&P Capital IQ Consensus, driven by increased patient demand, bulk sales to other Licensed Producers, and accelerated wholesale distribution in export markets.
- Preannounced rev $10.0-10.5 million vs. $9.9 mln ests last month.
- Total kilogram equivalents sold increased over two-fold to 1,613 kilograms from 684 kilograms in the prior year. Average net selling price per gram was $6.21 (C$7.98) compared to $7.53 (C$9.34) for the three months ended September 30, 2017.
No comments:
Post a Comment